MediciNova Inc (MNOV)vsRevolution Medicines Inc (RVMD)
MNOV
MediciNova Inc
$1.81
+4.02%
HEALTHCARE · Cap: $79.74M
RVMD
Revolution Medicines Inc
$205.11
+0.66%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
MediciNova Inc generates 24% more annual revenue ($920,480 vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. MNOV earns a higher WallStSmart Score of 30/100 (F).
MNOV
Avoid30
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 240.6% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Trading at 16.9x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : MNOV
The strongest argument for MNOV centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 240.6% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : MNOV
The primary concerns for MNOV are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
MNOV profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
MNOV is growing revenue faster at 240.6% — sustainability is the question.
RVMD generates stronger free cash flow (-745M), providing more financial flexibility.
Bottom Line
MNOV scores higher overall (30/100 vs 24/100) and 240.6% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MediciNova Inc
HEALTHCARE · BIOTECHNOLOGY · USA
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapies for the treatment of serious diseases with unmet medical needs in the United States. The company is headquartered in La Jolla, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?